The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Regenxbio Inc shares valued at $272,871 were sold by Mills Kenneth T. on Apr 15 ’24. At $18.19 per share, Mills Kenneth T. sold 15,000 shares. The insider’s holdings dropped to 408,035 shares worth approximately $6.57 million following the completion of this transaction.
Also, Mills Kenneth T. sold 15,000 shares, netting a total of over 327,942 in proceeds. Following the sale of shares at $21.86 each, the insider now holds 408,035 shares.
Before that, PAKOLA STEVE had sold 12,878 shares from its account. In a trade valued at $365,220, the Chief Medical Officer traded Regenxbio Inc shares for $28.36 each. Upon closing the transaction, the insider’s holdings decreased to 12,878 shares, worth approximately $1.73 million.
As published in their initiating research note from H.C. Wainwright on March 11, 2024, Regenxbio Inc [RGNX] has been a Buy and the price target has been revised to $36. Analysts at RBC Capital Mkts upgraded the stock from ‘”a Sector perform”‘ to ‘”an Outperform”‘ outlook in a report released in early March. As of March 06, 2024, Leerink Partners has increased its “Market perform” rating to a “an Outperform” for RGNX.
Analyzing RGNX Stock Performance
During the last five days, there has been a drop of approximately -15.30%. Over the course of the year, Regenxbio Inc shares have dropped approximately -10.25%. Shares of the company reached a 52-week high of $28.80 on 03/05/24 and a 52-week low of $11.83 on 02/02/24. A 50-day SMA is recorded $19.85, while a 200-day SMA reached $17.90. Nevertheless, trading volume fell to 0.56 million shares from 0.3 million shares the previous day.
Support And Resistance Levels for Regenxbio Inc (RGNX)
According to the 24-hour chart, there is a support level at 15.84, which, if violated, would cause prices to drop to 15.56. In the upper region, resistance lies at 16.60. The next price resistance is at 17.09. RSI (Relative Strength Index) is 25.98 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.92, which suggests the price will decrease in the coming days. Percent R is at 98.91%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
